Antimicrobial peptides as promising drugs for treatment of primary viral pneumonia
The COVID-19 pandemic which began in March 2020 has again drawn attention to the problem of treating primary viral pneumonia (PVP), wherein damage to the tissues of the lower respiratory tract including functionally important alveolocytes occurs as a result of cell infection by pathogens of the Vira...
Saved in:
Main Authors: | M. Yu. Shchelkanov, A. V. Cybulsky, V. G. Dedkov, I. V. Galkina, V. V. Maleev |
---|---|
Format: | article |
Language: | RU |
Published: |
Sankt-Peterburg : NIIÈM imeni Pastera
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/edfbbf9c547a4ae99b487a065c38211f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MUCOSAL MICROFLORA AND INNATE IMMUNITY OF UPPER RESPIRATORY TRACT IN INTRAUTERINE FOETAL INFECTION AND PNEUMONIA OF NEONATES
by: O. A. Svitich, et al.
Published: (2016) -
ASSOCIATION OF TLR2, TLR4, TLR9 GENE EXPRESSION RELATED TO INNATE IMMUNITY WITH IN VIVO ACUTE RESPIRATORY INFECTIONS CAUSED BY KLEBSIELLA PNEUMONIAE
by: E. V. Budanova, et al.
Published: (2018) -
Etiología viral en la neumonía del adulto adquirida en la comunidad en un hospital del sur de Chile
by: Rioseco Z,M. Luisa, et al.
Published: (2012) -
Post‐coronavirus disease 2019 organizing pneumonia confirmed pathologically by video‐assisted thoracoscopic surgery
by: Keishi Sugino, et al.
Published: (2021) -
Differential Diagnosis between Coronavirus Disease 2019 and Interstitial Pneumonia
by: PENG Min, et al.
Published: (2020)